Dr. Michael J Wagner, MD
Claim this profileDana-Farber Cancer Institute
Studies Liposarcoma
Studies Cancer
14 reported clinical trials
19 drugs studied
Area of expertise
1Liposarcoma
Stage IV
MDM2 positive
HLA-A positive
2Cancer
Stage IV
Stage III
MDM2 positive
Affiliated Hospitals
Clinical Trials Michael J Wagner, MD is currently running
BTX-A51
for Liposarcoma
This study is testing if the recommended dose of BTX-A51 is safe and tolerable in participants with liposarcoma. The name of the study drug used in this research study is: -BTX-A51 (a type of kinase inhibitor)
Recruiting1 award Phase 14 criteria
Intratumoral Microdosing
for Cancer
This trial uses a device to inject small amounts of cancer drugs directly into tumors of patients undergoing surgery. The device marks where each drug is injected, allowing researchers to see how different parts of the tumor respond. This helps test cancer drugs early without causing widespread side effects. The device has been shown to induce strong, easily tracked, drug-specific responses in tumors while avoiding toxicity, setting the stage for its application in clinical trials.
Recruiting1 award Phase < 17 criteria
More about Michael J Wagner, MD
Clinical Trial Related5 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Michael J Wagner, MD has experience with
- Paclitaxel
- Nivolumab
- Pembrolizumab
- BTX-A51
- Itacitinib
- Fludarabine
Breakdown of trials Michael J Wagner, MD has run
Synovial Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael J Wagner, MD specialize in?
Michael J Wagner, MD focuses on Liposarcoma and Cancer. In particular, much of their work with Liposarcoma has involved Stage IV patients, or patients who are MDM2 positive.
Is Michael J Wagner, MD currently recruiting for clinical trials?
Yes, Michael J Wagner, MD is currently recruiting for 5 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Michael J Wagner, MD has studied deeply?
Yes, Michael J Wagner, MD has studied treatments such as Paclitaxel, Nivolumab, Pembrolizumab.
What is the best way to schedule an appointment with Michael J Wagner, MD?
Apply for one of the trials that Michael J Wagner, MD is conducting.
What is the office address of Michael J Wagner, MD?
The office of Michael J Wagner, MD is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.